FP K 975

Traduzione non disponibile. Testo originale, lingua: inglese.

Treatment of prevention of hypokalemia which does not result from dietary deficiency. Treatment of digitalis toxicity. Potassium replacement therapy. Electrolyte replenisher. For the treatment of metabolic alkalosis.

Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze · 2010-12-16

Traduzione non disponibile. Testo originale, lingua: inglese.

Cautions and Warnings : To be taken only on the advice of a health care practitioner. Where impaired renal function exists, the use of potassium supplements must be monitored closely. The use of potassium supplements with potassium sparing diuretics (spironolactone, triamterene, amiloride) may lead to hyperkalemia) may lead to hyperkalemia. Not to be used following vigorous exercise or acute dehydration (unless administered with an appropriate balance of other mineral salts, e.g. sodium). Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Discontinue use and consult a health care practitioner immediately if you experience numbness of the extremities, muscle weakness, paralysis, cardiac arrhythmias, low blood pressure, or confusion. Consult a health care practitioner prior to use if you have a kidney or heart condition. Do not use if you have adrenal insufficiency or uncontrolled diabetes mellitus. Do not use with other potassium-containing supplements or with potassium-containing salt-substitutes. May cause nausea, vomiting, diarrhea, abdominal cramps; discontinue use and consult a health care practitioner if these symptoms are severe.

Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze · 2010-12-16

Traduzione non disponibile. Testo originale, lingua: inglese.

Contra-Indications : Contraindictaed in patients with Hyperkalemia since a further increase in potassium concentration in such patients can produce cardiac arrest. Hyperkalemia may complicate any of the following conditions: acute and chronic renal failure, systemic acidosis such as diabetic acidosis; acute dehydration, extensive tissue breakdown as in severe burns, adrenal insufficiency, or the administration of potassium-sparring diuretic (e.g. Spironolactone, Triamterene, Amiloride), or other drugs causing Hyperkalemia such as Captopril and Enalapril. All solid dosage forms of potassium are contraindicated in any patients in whom there is cause of arrest or delay in tablet passage through the gastrointestinal tract. In these instances, potassium supplementation should be with a liquid preparation.

Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze · 2010-12-16

Traduzione non disponibile. Testo originale, lingua: inglese.

Known Adverse Reactions : The most common adverse reactions to oral potassium salts are nausea, vomiting, abdominal discomfort and diarrhea. These symptoms are due to irritation of the gastrointestinal tract and are best avoided by increasing fluid intake when possible, taking the dose with meals or reducing the dose. Intestinal bleeding, ulceration, perforation and obstruction have been reported in patients treated with solid dosage forms of potassium salts and may occur with FP K 975. One of the most severe adverse ffects is Hyperkalemia. Skin rash has been reported rarely with potassium preparations.

Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze · 2010-12-16